Glioblastoma—a moving target
Open Access
- 18 April 2012
- journal article
- review article
- Published by Uppsala Medical Society in Upsala Journal of Medical Sciences
- Vol. 117 (2) , 251-256
Abstract
The slow development of effective treatment of glioblastoma is contrasted by the rapidly advancing research on the molecular mechanisms underlying the disease. Amplification and overexpression of receptor tyrosine kinases, particularly EGFR and PDGFRA, are complemented by mutations in the PI3K, RB1, and p53 signaling pathways. In addition to finding effective means to target these pathways, we may take advantage of the recent understanding of the hierarchical structure of tumor cell populations, where the progressive expansion of the tumor relies on a minor subpopulation of glioma stem cells, or glioma-initiating cells. Finding ways to reprogram these cells and block their self-renewal is one of the most important topics for future research.Keywords
This publication has 53 references indexed in Scilit:
- Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant gliomaJournal of Clinical Investigation, 2012
- Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 ProteinJournal of Biological Chemistry, 2011
- RAD51 can inhibit PDGF-B–induced gliomagenesis and genomic instabilityNeuro-Oncology, 2011
- Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchyGlia, 2011
- Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastomaProceedings of the National Academy of Sciences, 2011
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box FactorsCell Stem Cell, 2009
- Cancer stem cells: mirage or reality?Nature Medicine, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997